Renalytix announces collaboration with Steno Diabetes Center

Renalytix announces a collaboration with the Steno Diabetes Center, Copenhagen, to advance translation of precision medicine solutions for patients with Diabetes and Chronic Kidney Disease, DKD. The initial focus of the collaboration will be on developing a roadmap for implementation of KidneyIntelX at the Steno Diabetes Center and affiliated practices. Through this collaboration Renalytix and Steno will investigate core elements necessary for successful clinical translation of KidneyIntelX in a European context, beginning with integration of the biomarker testing into laboratory workflows, education of clinicians and patients on the role of KidneyIntelX risk assessment in the continuum of care and, leveraging of electronic health record systems for efficient, risk-based care management. Importantly, this is expected to launch the first use of Renalytix’s KidneyIntelX platform outside the US to showcase the clinical utility in the EU by utilizing advanced technology to provide better informed care for solving chronic kidney disease.